Literature DB >> 10685926

Diagnosing idiopathic/cryptogenic epilepsy syndromes in infancy.

N Sarisjulis1, B Gamboni, P Plouin, A Kaminska, O Dulac.   

Abstract

PURPOSE: To determine the characteristics that permit diagnosis of the type of epilepsy beginning in the 1st year of life, and to determine from what age such characteristics are recognisable. PATIENTS: From 430 non-selected patients who began having seizures in the 1st year of life and were referred to the neuropaediatric department of Saint Vincent de Paul Hospital, those with epileptic spasms as the first seizure type, those with recognisable aetiology, and those for whom early history was not reliable were excluded.
METHODS: For the remaining 140 patients, the age at which clinical and electroencephalogram (EEG) characteristics met those of recognisable epilepsy syndromes according to the ILAE classification was studied.
RESULTS: In most epilepsy syndromes, the diagnosis could be made within three months of onset of the disorder. The most difficult was to distinguish cryptogenic localisation related epilepsy from severe myoclonic epilepsy in infancy. Repeat focal seizures and persisting spike focus were the earliest and most reliable signs of localisation related epilepsy, whereas alternating focal seizures, generalised myoclonus, and/or spike waves appeared before the end of the 1st year in most infants with severe myoclonic epilepsy. However, for 39 patients it was not possible to reach the diagnosis of a precise syndrome.
CONCLUSION: For over three quarters of infants with cryptogenic/idiopathic epilepsy, it is possible to reach a syndromic diagnosis within the first months of the disease, based on clinical and EEG characteristics. However, for one quarter, no diagnosis is possible based on the currently available classification.

Entities:  

Mesh:

Year:  2000        PMID: 10685926      PMCID: PMC1718261          DOI: 10.1136/adc.82.3.226

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  19 in total

Review 1.  Early myoclonic encephalopathy, early infantile epileptic encephalopathy, and benign and severe infantile myoclonic epilepsies: a critical review and personal contributions.

Authors:  C T Lombroso
Journal:  J Clin Neurophysiol       Date:  1990-07       Impact factor: 2.177

2.  BAEP latency changes during nocturnal sleep are not correlated with sleep stages but with body temperature variations.

Authors:  H Bastuji; L Garcia Larrea; O Bertrand; F Mauguière
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1988-07

3.  The epileptic syndrome sharing common characteristics during early childhood with severe myoclonic epilepsy in infancy.

Authors:  T Ogino; Y Ohtsuka; Y Yamatogi; E Oka; S Ohtahara
Journal:  Jpn J Psychiatry Neurol       Date:  1989-09

4.  The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967.

Authors:  W A Hauser; L T Kurland
Journal:  Epilepsia       Date:  1975-03       Impact factor: 5.864

5.  Convulsive disorders in the first year of life: etiologic factors.

Authors:  J J Chevrie; J Aicardi
Journal:  Epilepsia       Date:  1977-12       Impact factor: 5.864

6.  Complex partial seizures of infancy.

Authors:  M S Duchowny
Journal:  Arch Neurol       Date:  1987-09

7.  Convulsive disorders in the first year of life: neurological and mental outcome and mortality.

Authors:  J J Chevrie; J Aicardi
Journal:  Epilepsia       Date:  1978-02       Impact factor: 5.864

8.  Benzodiazepines in the treatment of children with epilepsy.

Authors:  K Farrell
Journal:  Epilepsia       Date:  1986       Impact factor: 5.864

9.  [Monotherapy with clobazam in epilepsies in children].

Authors:  O Dulac; D Figueroa; E Rey; M Arthuis
Journal:  Presse Med       Date:  1983-04-16       Impact factor: 1.228

10.  [Treatment of infantile spasms with vigabatrin as first-line therapy and in monotherapy: apropos of 70 infants].

Authors:  N Villeneuve; C Soufflet; P Plouin; C Chiron; O Dulac
Journal:  Arch Pediatr       Date:  1998-07       Impact factor: 1.180

View more
  5 in total

1.  Novel SCN1A mutation in a proband with malignant migrating partial seizures of infancy.

Authors:  Emily R Freilich; Julie M Jones; William D Gaillard; Joan A Conry; Tammy N Tsuchida; Christine Reyes; Sulayman Dib-Hajj; Stephen G Waxman; Miriam H Meisler; Phillip L Pearl
Journal:  Arch Neurol       Date:  2011-05

Review 2.  Advances in our understanding of early childhood epilepsies: 1999-2000.

Authors:  D R Nordli; E Wyllie; K D Holland
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

3.  Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures.

Authors:  E Novotny; B Renfroe; N Yardi; D Nordli; S Ness; S Wang; T Weber; C L Kurland; E Yuen; M Eerdekens; L Venkatraman; J S Nye; L Ford
Journal:  Neurology       Date:  2010-01-20       Impact factor: 9.910

Review 4.  Infantile seizures: infants are not just little children.

Authors:  David T Hsieh; Jennifer M Walker; Phillip L Pearl
Journal:  Curr Neurol Neurosci Rep       Date:  2008-03       Impact factor: 5.081

5.  The Role of Focal Epilepsy Features in Defining SCN1A Mutation-positive Dravet Syndrome as Generalized and Focal Epilepsy.

Authors:  Young Jun Ko; Il Han Yoo; Jiwon Lee; Jeehun Lee; Mi-Sun Yum; Tae-Sung Ko; Hunmin Kim; Hee Hwang; Soo Yeon Kim; Jong-Hee Chae; Ji-Eun Choi; Ki Joong Kim; Byung Chan Lim
Journal:  J Epilepsy Res       Date:  2021-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.